The Pillar Post

Development and Evaluation of a Lung Cancer Fusion Panel

Development and Evaluation of a Lung Cancer Fusion Panel

August 27, 2018 by Dale Yuzuki

At this year’s Next Generation Diagnostics Conference held in Washington DC, Pillar Biosciences presented a poster entitled “Development and Evaluation of a Lung Cancer Fusion RNA Panel” with first author Pillar Biosciences’ staff scientist Dr. Nick Lodato and senior author Pillar Biosciences’ CSO Dr. Zhaohui Wang.

This poster reviews the assay principle behind Pillar Biosciences’ Lung Cancer Fusion RNA Panel, the types of fusions interrogated, and presents results from 40 samples with known fusions from a variety of sources. You can find this poster, and several others collaborators have produced, at our Resources Page.